Questions?
(888) 391-1315

INCRETIN DRUG SIDE EFFECTS?

If you or a family member were diagnosed with pancreatic cancer after using an incretin drug, you may be among the thousands eligible to file a claim against the manufacturer.

free case review

Thank you for contacting DrugNews. Your inquiry has been forwarded to one of our Patient Advocates. A representative should be in touch with you in less than 24 hours but hopefully much sooner. 

For immediate information, you can reach us on our 24/7 Defective Drug Hotline at 1-888-391-1315.

Oops! Something went wrong while submitting the form :(

Testimonials

“Love Drugnews and all the great information. The patient advocate I spoke with was knowledgable on the drug I was taking and knew exactly whether or not my side effects qualified to file a claim. It was a very easy phone call and I spoke with my lawyer that very same day.”

- Susan from Madison, WI

“I was diagnosed with bladder cancer after taking Actos but was hesitant to call a lawyer. They helped me choose a firm that specialized in helping victims with my exact problems.”

- Jim from Palm Beach, FL
free case review

speak with a patient advocate

A patient advocate can provide you with the latest Incretin drug warnings from the FDA, update you on the litigation against the manufacturer, and connect you with a lawyer today.

side effects injury

learn about side effects

Multiple U.S. And European studies have linked incretin drug use with significant increases in the risk of pancreatic cancer. Learn more about the symptoms and how to protect yourself.

legal claim

understand your legal rights

Thousands of patients have filed lawsuits against drug companies after being diagnosed with pancreatic cancer. You may be eligible for compensation.

drug settlement

file a Defective Drug claim

It costs nothing to investigate your case or file a claim. And, DrugNews can qualify your case and have you talking to a lawyer in minutes.

Assistance is available now.

Call (888) 391-1315 to speak with a patient advocate.